Not your father’s launches The leading members of the pharmaceutical industry’s new compound class of 2013 have set a new standard for launch success. Remember when a drug that […]
A difficult feat to accomplish in business is to make dramatic change in the midst of current success. History is littered with companies that were once on top of the […]
What do you get when you combine Obamacare with an expected explosion in the use of pricey drugs and the rapid aging of the Baby Boomer population? The answer, courtesy […]
WATERTOWN, Mass.–(BUSINESS WIRE)–Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that the U.S. Food […]
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for […]
BLOOMFIELD, Conn.–(BUSINESS WIRE)–A Cigna (NYSE: CI) analysis has found that 98.4 percent of Cigna Pharmacy Management customers treated with Harvoni for hepatitis C genotype 1 achieved a sustained virologic response […]
UnitedHealth Group (UNH), buoyed by growth potential of its expanding pharmacy benefit business, raised its earnings outlook with the coming addition of a much larger drug management operation. The nation’s […]
